Simurosertib (Standard)
Simurosertib (Standard) is the analytical standard of Simurosertib. This product is intended for research and analytical applications. Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of.
Product Specifications
CAS Number
1330782-76-7
Target
CDK; Reference Standards
Related Pathways
Cell Cycle/DNA Damage; Others
Field of Research
Cancer
Smiles
O=C1C2=C(C=C(C3=CNN=C3C)S2)NC([C@H]4N(CC5)CCC5C4)=N1
Molecular Formula
C17H19N5OS
Molecular Weight
341.43
References & Citations
[1]K Iwai, et al. A novel CDC7-selective inhibitor TAK-931 with potent antitumor activity. European Journal of Cancer , 2016 , 69 (1) :S34.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881429-500 1x 500 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401922-500 1x 500 µL
TPO (Thyroid Peroxidase) (Thyroid Marker) (TPO/1922), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681634-100 1x 100 µL
P53 Tumor Suppressor Protein (PAb240), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880673-500 1x 500 µL
Cyclin A2 (E67), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details